Description
Contacts of leprosy patients have an elevated risk of developing leprosy themselves. A number of innovative approaches to improve the efficacy of chemo- and immunoprophylaxis are being explored.
Innovations in Leprosy Prophylaxis: Current Evidence and Upcoming Trials
Related Items
-
DocumentlockLeprosy Post-exposure Prophylaxis with Single-dose Rifampicin (LPEP): An International Feasibility Programme -
DocumentlockLeprosy Diagnostic Test Development As a Prerequisite Towards Elimination: Requirements from the User’s Perspective -
DocumentlockAn Innovative Approach to Screening and Chemoprophylaxis among Contacts of Leprosy Patients in Low Endemic Settings: Experiences from Cambodia -
DocumentlockMinimal Essential Data to Document Contact Tracing and Single Dose Rifampicin (SDR) for Leprosy Control in Routine Settings: A Practical Guide